Stock Report

All about this stock under one free report Last Updated: 15-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Nanobiotix (NBTX)

Stock Card factsheet share-fund-plan-icon

$49.85

up-down-arrow $-5.22 (-9.48%)

As on 15-May-2026 10:32EDT

Market cap

info icon

$2,597 Mln

Revenue (TTM)

info icon

$-- Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

65

Div. Yield

info icon

0 %

Nanobiotix (NBTX) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 49.72 High: 53.95

52 Week Range

Low: 3.60 High: 57.14

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-- Mln

  • ROEROE information

    -2 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -2.4

  • Debt to EquityDebt to Equity information

    -1.1

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.5

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    48,495,512

10 Years Aggregate

CFO

€-238.85 Mln

EBITDA

€-293.05 Mln

Net Profit

€-332.76 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Nanobiotix (NBTX)
115.6 56.6 96.7 1,186.5 117.6 26.4 --
BSE Sensex
-11.1 -2.1 -8.9 -7.5 6.6 9.1 11.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 15-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
Nanobiotix (NBTX)
705.6 -60.3 98.4 -54.7 -50.9
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3
BSE Sensex
9.1 8.1 18.7 4.4 22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in (€ Mln)

Annual

*All values are in (€ Mln)

Annual

*All values are in (€ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Nanobiotix (NBTX)
49.9 2,596.9 29.6 -24.0 -- 31.9 -- 65.0
Fresenius Medical Care AG - ADR
21.7 11,687.9 19,358.7 944.6 9.0 5.5 11.3 0.8
Galapagos NV - ADR
27.5 1,862.3 1,043.8 488.8 -19.0 16 3.2 0.5
Innate Pharma S.A. ADS - ADR
2.1 133.2 2.8 -47.2 -86.4 734.6 -- 20.1
Inventiva Sa (IVA)
5.5 1,204.4 4.5 -340.2 -518.6 501.4 -- 2.1
Valneva SE - ADR
5.8 597.4 174.7 -115.2 0.0 -80.2 -- 4.3

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Nanobiotix (NBTX)

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline...  hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012  Read more

  • Co-Founder, President of the Executive Board & CEO

    Mr. Laurent Levy Ph.D.

  • Co-Founder, President of the Executive Board & CEO

    Mr. Laurent Levy Ph.D.

  • Headquarters

    Paris

  • Website

    https://www.nanobiotix.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Nanobiotix (NBTX)

The share price of Nanobiotix (NBTX) is $49.85 (NASDAQ) as of 15-May-2026 10:32 EDT. Nanobiotix (NBTX) has given a return of 117.57% in the last 3 years.

Since, TTM earnings of Nanobiotix (NBTX) is negative, P/E ratio is not available.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-46.14
-13.09
2024
-1.99
-2.06
2023
-7.12
-153.26
2022
-2.24
-4.73
2021
-6.00
10.52

The 52-week high and low of Nanobiotix (NBTX) are Rs 57.14 and Rs 3.60 as of 15-May-2026.

Nanobiotix (NBTX) has a market capitalisation of $ 2,597 Mln as on 12-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Nanobiotix (NBTX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.